Lorazepam

País: Armenia

Idioma: inglés

Fuente: Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

Ingredientes activos:

lorazepam

Disponible desde:

Arpimed LLC

Designación común internacional (DCI):

lorazepam

Dosis:

1mg

formulario farmacéutico:

tablets

tipo de receta:

Prescription

Ficha técnica

SUMMARY PRODUCT CHARACTERISTIC (SPC)
LORAZEPAM 1 MG
AND 2 MG TABLETS
1.1
BRAND NAME - LORAZEPAM
1.2
INTERNATIONAL NON-PROPERTY NAME - LORAZEPAM
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
Each Lorazepam 1 mg tablet contains:
_ACTIVE INGREDIENT: _lorazepam - 1 mg
_For a full list of excipients, see section 6.1. _
Each Lorazepam 2 mg tablet contains:
_ACTIVE INGREDIENT: _lorazepam - 2 mg
_For a full list of excipients, see section 6.1. _
3.
PHARMACEUTICAL FORM
_Lorazepam, 1 mg tablets _
White or off white scored cylindrical tablets with a few small darker
spots and with a risk on one side and a
facet on both sides. _Lorazepam, 2 mg tablets _
White scored cylindrical tablets with a risk on one side and a facet
on both sides.
4.
CLINICAL PARTICULARS
4.1
THERAPEUTIC INDICATIONS
Lorazepam is indicated for the short term treatment of unacceptable
disabling or distressful anxiety states
including anxiety associated with psychosomatic, organic and psychotic
illness, and the short term treatment of
insomnia associated with anxiety. Lorazepam may also be used as
premedication before operative dentistry and
general surgery.
4.2
POSOLOGY AND METHOD OF ADMINISTRATION POSOLOGY:
Dosage and duration of therapy should be individualised. The lowest
effective dose should be prescribed for the
shortest time possible. The risk of withdrawal and rebound phenomena
is greater after abrupt discontinuation;
therefore, the drug should be discontinued gradually for all patients
(see section 4.4). Generally, the duration of
treatment varies from a few days to 4 weeks including the tapering off
process. Extension of the treatment
period should not take place without reevaluation of the need for
continued therapy.
Increases in the dosage of lorazepam should be made gradually to help
avoid adverse effects. The evening dose
should be increased before the daytime doses.
DOSAGE:
ADULTS:
Moderate and severe anxiety:
Insomnia:
Premedication
before
operative
dentistry
or
general
surgery: 1-4 mg daily in divided doses.
1-2 mg before retiring
2- 3 mg th